Exhibit 99.1
|
Press Release
|
Eltek Reports 2021 Second Quarter Financial Results
| • |
Revenues of $9.1 million in the second quarter of 2021 compared to $8.8 million in the second quarter of 2020
|
| • |
Gross profit of $2.4 million in the second quarter of 2021 compared to $1.9 million in the second quarter of 2020
|
| • |
Net profit of $825,000 in the second quarter of 2021 compared to net profit of $704,000 in the second quarter of 2020
|
| • |
Achieved EBITDA of $1.4 million in the second quarter of 2021, or 15.2% of total sales compared to EBITDA of $1.2 million in the second quarter of 2020
|
| • |
Cash and cash equivalents as of June 20, 2021 were $9.2 million
|
PETACH-TIKVA, Israel, August 18, 2021 - Eltek Ltd. (NASDAQ: ELTK), a global manufacturer and supplier of technologically advanced solutions in the field of printed circuit boards, announced
today its financial results for the quarter ended June 30, 2021.
Mr. Eli Yaffe, Chief Executive Officer, commented: "We are pleased that our second quarter reflects the return to improved results. We are gratified that
despite the global Covid-19 pandemic that resulted in the short supply of various critical raw materials and the related challenges, we were able to grow our top line by 3.9% compared to the second quarter of 2020 and improve our gross margins from
21.6% in Q2 2020 to 25.9% in Q2 2021."
“We are operating in a challenging business environment these days, mainly due to the global supply chain crisis, which was not resolved yet. As previously announced, during 2021 we were impacted
by the worldwide shortage of Pyralux AP, a key material produced by DuPont. During the second quarter we were able to obtain authorizations from some of our customers to use alternative raw materials.” added Mr. Yaffe.
“During the second quarter we faced price increases for some of our raw materials. In addition, some of our operating expenses are dominated in New Israeli Shekel (“NIS”) and were negatively
affected due to the devaluation of the US$ against the NIS. Nevertheless these challenges, we were able to improve our gross margin in the second quarter” said Mr. Yaffe.
“We are conducting several R&D programs and making effort to become an innovative industry leader. Eltek is making the necessary operational adjustments to expand our business, improve customer
satisfaction, increase revenues, maintain the trend of improved operational results,” concluded Mr. Yaffe.
Highlights of the Second Quarter of 2021 compared to the Second Quarter of 2020
| • |
Revenues for the second quarter of 2021 were $9.1 million compared to revenues of $8.8 million in the second quarter of 2020;
|
| • |
Gross profit increased to $2.4 million (25.9% of revenues) in the second quarter of 2021 compared to $1.9 million (21.6% of revenues) in the second quarter of 2020;
|
| • |
Operating profit increased to $944,000 (10.3% of revenues) during the second quarter of 2021 as compared to operating profit of $809,000 (9.2% of revenues)in the second quarter of 2020;
|
| • |
Net profit was $825,000, or $0.14 per fully diluted share in the second quarter of 2021 compared to net profit of $704,000, or $0.16 per fully diluted share, in the second quarter of 2020;
|
| • |
EBITDA was $1.4 million in the second quarter of 2021 compared to EBITDA of $1.2 million in the second quarter of 2020;
|
| • |
Net cash provided by operating activities amounted to $380,000 in the second quarter of 2021 compared to net cash provided by operating activities of $1.4
million in the second quarter of 2020.
|
| • |
Cash and cash equivalents as of June 30, 2021 were $9.2 million compared to $4.7 million as of December 31, 2020.
|
Highlights for the First Six Months of 2021
| • |
Revenues for the first six months of 2021 were $16.3 million compared to $17.9 million in the first six months of 2020;
|
| • |
Gross profit was $3.5 million (21.5% of revenues) compared to gross profit of $3.7 million (20.6% of revenues) in the first six months of 2020;
|
| • |
Operating profit was $1.1 million compared to operating profit of $1.4 million in the first six months of 2020;
|
| • |
Net profit was $1.0 million, or $0.18 per fully diluted share compared to net profit of $1.2 million, or $0.28 per fully diluted share in the first six months of 2020;
|
| • |
EBITDA was $2.0 million in the first six months of 2021, compared to EBITDA of $2.2 million in the first six months of 2020;
|
| • |
Net cash provided by operating activities amounted to $2.8 million in the first six months of 2021 compared to net cash provided by operating activities of $2.9 million in the first six months of
2020.
|
Conference Call
Today, Wednesday, August 18, 2021, at 8:00 a.m. Eastern Time, Eltek will conduct a conference call to discuss the results. The call will feature remarks by Eli Yaffe, Chief
Executive Officer and Alon Mualem, Chief Financial Officer.
To participate, please call the following teleconference numbers. Please allow for additional time to connect prior to the call:
|
United States:
|
1-888-723-3164
|
| Israel: | 03-9180691 |
| International: | +972-3-9180691 |
|
|
At:
8:00 a.m. Eastern Time
5:00 a.m. Pacific Time
15:00 p.m. Israel Time
|
A replay of the call will be available through the Investor Info section on Eltek’s corporate website at http://www.nisteceltek.com approximately 24 hours after the
conference call is completed and will be archived for 30 days.
About Eltek
Eltek – "Innovation Across the Board", is a global manufacturer and supplier of technologically advanced solutions in the field of printed circuit boards (PCBs), and is the Israeli leader in this
industry. PCBs are the core circuitry of most electronic devices. Eltek specializes in the manufacture and supply of complex and high quality PCBs, HDI, multilayered and flex-rigid boards for the high-end market. Eltek is ITAR compliant and has
AS-9100 and NADCAP Electronics certifications. Its customers include leading companies in the defense, aerospace and medical industries in Israel, the United States, Europe and Asia.
Eltek was founded in 1970. The Company’s headquarters, R&D, production and marketing center are located in Israel. Eltek also operates through its subsidiaries in North America and by agents
and distributors in Europe, India, South Africa and South America.
For more information, visit Eltek's web site at www.nisteceltek.com.
Use of Non-GAAP Financial Information
The Company reports financial results in accordance with U.S. GAAP and herein provides some non-GAAP measures, including EBITDA. These non-GAAP measures are not in accordance with, nor are they a
substitute for, GAAP measures. These non-GAAP measures are intended to supplement the Company’s presentation of its financial results that are prepared in accordance with GAAP. The Company uses the non-GAAP measures presented to evaluate and manage
the Company’s operations internally. The Company is also providing this information to assist investors in performing additional financial analysis. Reconciliation between the company's results on a GAAP and non-GAAP basis is provided in a table
below.
Forward Looking Statement:
Certain matters discussed in this news release are forward-looking statements that involve a number of risks and uncertainties including, but not limited to statements regarding expected results in
future quarters, the impact of the Coronavirus on the economy and our operations, risks in product and technology development and rapid technological change, product demand, the impact of competitive products and pricing, market acceptance, the
sales cycle, changing economic conditions and other risk factors detailed in the Company's Annual Report on Form 20-F and other filings with the United States Securities and Exchange Commission.
Investor Contact:
Alon Mualem
Chief Financial Officer
alonm@nisteceltek.com
Chief Financial Officer
alonm@nisteceltek.com
+972-3-9395023
(Tables follow)
Eltek Ltd.
Consolidated Statements of Operations
(In thousands US$, except per share data)
|
Three months ended
|
Six months ended
|
|||||||||||||||
|
June 30,
|
June 30,
|
|||||||||||||||
|
2021
|
2020
|
2021
|
2020
|
|||||||||||||
|
Revenues
|
9,132
|
8,792
|
16,338
|
17,949
|
||||||||||||
|
Costs of revenues
|
(6,765
|
)
|
(6,892
|
)
|
(12,827
|
)
|
(14,246
|
)
|
||||||||
|
Gross profit
|
2,367
|
1,900
|
3,511
|
3,703
|
||||||||||||
|
Selling, general and administrative expenses
|
(1,413
|
)
|
(1,095
|
)
|
(2,421
|
)
|
(2,284
|
)
|
||||||||
|
R&D expenses, net
|
(10
|
)
|
4
|
(10
|
)
|
2
|
||||||||||
|
Operating profit
|
944
|
809
|
1,080
|
1,421
|
||||||||||||
|
Financial expenses, net
|
(84
|
)
|
(83
|
)
|
20
|
(139
|
)
|
|||||||||
|
Other income, net
|
-
|
-
|
(3
|
)
|
-
|
|||||||||||
|
Profit before income tax
|
860
|
726
|
1,097
|
1,282
|
||||||||||||
|
Tax expenses
|
(35
|
)
|
(22
|
)
|
(50
|
)
|
(38
|
)
|
||||||||
|
Net Profit
|
825
|
704
|
1,047
|
1,244
|
||||||||||||
|
Earnings per share
|
||||||||||||||||
|
Basic and diluted net profit per ordinary share
|
0.14
|
0.16
|
0.18
|
0.28
|
||||||||||||
|
Weighted average number of ordinary shares used to compute
|
||||||||||||||||
|
basic net profit per ordinary share (in thousands)
|
5,840
|
4,380
|
5,840
|
4,380
|
||||||||||||
|
Weighted average number of ordinary shares used to compute
|
||||||||||||||||
|
diluted net profit per ordinary share (in thousands)
|
5,871
|
4,380
|
5,868
|
4,380
|
||||||||||||
Eltek Ltd.
Consolidated Balance Sheets
(In thousands US$)
|
June 30,
|
December 31,
|
|||||||
|
2021
|
2020
|
|||||||
|
Assets
|
||||||||
|
Current assets
|
||||||||
|
Cash and cash equivalents
|
9,169
|
4,735
|
||||||
|
Receivables: Trade, net of provision for doubtful accounts
|
7,388
|
9,062
|
||||||
|
Other
|
784
|
700
|
||||||
|
Inventories
|
3,904
|
3,704
|
||||||
|
Prepaid expenses
|
422
|
619
|
||||||
|
Total current assets
|
21,667
|
18,820
|
||||||
|
Long term assets
|
||||||||
|
Restricted deposits
|
215
|
62
|
||||||
|
Severance pay fund
|
63
|
64
|
||||||
|
Operating lease right of use assets
|
8,801
|
8,948
|
||||||
|
Total long term assets
|
9,079
|
9,074
|
||||||
|
Fixed assets, less accumulated depreciation
|
6,893
|
7,263
|
||||||
|
Total Assets
|
37,639
|
35,157
|
||||||
|
Liabilities and Shareholder's equity
|
||||||||
|
Current liabilities
|
||||||||
|
Short-term credit and current maturities of long-term debts
|
502
|
676
|
||||||
|
Accounts payable: Trade
|
3,881
|
4,452
|
||||||
|
Other
|
3,499
|
3,831
|
||||||
|
Short-term operating lease liabilities
|
806
|
742
|
||||||
|
Total current liabilities
|
8,688
|
9,701
|
||||||
|
Long-term liabilities
|
||||||||
|
Long term debt, excluding current maturities
|
4,125
|
1,495
|
||||||
|
Employee severance benefits
|
323
|
338
|
||||||
|
Deferred tax liabilities
|
99
|
84
|
||||||
|
Long-term operating lease liabilities
|
8,085
|
8,272
|
||||||
|
Total long-term liabilities
|
12,632
|
10,189
|
||||||
|
Equity
|
||||||||
|
Ordinary shares, NIS 3.0 par value authorized 10,000,000 shares, issued and outstanding 5,840,357
|
5,296
|
5,296
|
||||||
|
Additional paid-in capital
|
22,846
|
22,846
|
||||||
|
Cumulative foreign currency translation adjustments
|
2,975
|
3,153
|
||||||
|
Capital reserve
|
1,267
|
1,084
|
||||||
|
Accumulated deficit
|
(16,065
|
)
|
(17,112
|
)
|
||||
|
Shareholders' equity
|
16,319
|
15,267
|
||||||
|
Total liabilities and shareholders' equity
|
37,639
|
35,157
|
||||||
Eltek Ltd.
Unaudited Non-GAAP EBITDA Reconciliations
(In thousands US$)
|
Non-GAAP EBITDA Reconciliations
|
Three months ended
|
Six months ended
|
||||||||||||||
|
June 30,
|
June 30,
|
|||||||||||||||
|
2021
|
2020
|
2021
|
2020
|
|||||||||||||
|
Unaudited
|
Unaudited
|
|||||||||||||||
|
GAAP net Income (loss)
|
825
|
704
|
1,047
|
1,244
|
||||||||||||
|
Add back items:
|
||||||||||||||||
|
Financial expenses, net
|
84
|
83
|
(20
|
)
|
139
|
|||||||||||
|
Income tax expense
|
35
|
22
|
50
|
38
|
||||||||||||
|
Depreciation and amortization
|
442
|
391
|
885
|
786
|
||||||||||||
|
Non-GAAP EBITDA
|
1,386
|
1,200
|
1,962
|
2,207
|
||||||||||||
Eltek Ltd.
Consolidated Statement of Cash flow
(In thousands US$)
|
Three months ended
|
Six months ended
|
|||||||||||||||
|
June 30,
|
June 30,
|
|||||||||||||||
|
2021
|
2020
|
2021
|
2020
|
|||||||||||||
|
Cash flows from operating activities:
|
||||||||||||||||
|
Net Income
|
825
|
704
|
1,047
|
1,244
|
||||||||||||
|
Adjustments to reconcile net profit to net
|
||||||||||||||||
|
cash flows provided by operating activities:
|
||||||||||||||||
|
Depreciation and amortization
|
442
|
391
|
886
|
786
|
||||||||||||
|
Stock-based compensation
|
170
|
17
|
183
|
43
|
||||||||||||
|
Revaluation of long term loans
|
-
|
(6
|
)
|
-
|
4
|
|||||||||||
|
Increase in deferred tax liabilities
|
9
|
6
|
16
|
12
|
||||||||||||
|
621
|
408
|
1,085
|
845
|
|||||||||||||
|
Decrease (increase) in operating lease right-of-use assets
|
20
|
1
|
24
|
(4
|
)
|
|||||||||||
|
Decrease (increase) in trade receivables
|
(1,482
|
)
|
280
|
1,546
|
149
|
|||||||||||
|
Decrease in other receivables and prepaid expenses
|
315
|
49
|
95
|
187
|
||||||||||||
|
Decrease (increase) in inventories
|
252
|
27
|
(250
|
)
|
248
|
|||||||||||
|
Decrease in trade payables
|
(211
|
)
|
(113
|
)
|
(411
|
)
|
(370
|
)
|
||||||||
|
Increase (decrease) in other liabilities and accrued expenses
|
44
|
17
|
(279
|
)
|
538
|
|||||||||||
|
Increase (decrease) in employee severance benefits, net
|
(4
|
)
|
24
|
(10
|
)
|
40
|
||||||||||
|
(1,066
|
)
|
285
|
715
|
788
|
||||||||||||
|
Net cash provided by operating activities
|
380
|
1,397
|
2,847
|
2,877
|
||||||||||||
|
Cash flows from investing activities:
|
||||||||||||||||
|
Purchase of fixed assets
|
(331
|
)
|
(250
|
)
|
(538
|
)
|
(454
|
)
|
||||||||
|
Restricted deposits
|
(154
|
)
|
(58
|
)
|
(154
|
)
|
(58
|
)
|
||||||||
|
Net cash used in investing activities
|
(485
|
)
|
(308
|
)
|
(692
|
)
|
(512
|
)
|
||||||||
|
Cash flows from financing activities:
|
||||||||||||||||
|
Short- term bank credit, net
|
-
|
(326
|
)
|
(377
|
)
|
(765
|
)
|
|||||||||
|
Repayment of short- term shareholder loan
|
-
|
(571
|
)
|
-
|
(571
|
)
|
||||||||||
|
Repayment of long-term loans from bank
|
(38
|
)
|
(35
|
)
|
(77
|
)
|
(108
|
)
|
||||||||
|
Proceeds from long-term loans
|
3,062
|
1,141
|
3,062
|
1,141
|
||||||||||||
|
Repayment of credit from fixed asset payables
|
(274
|
)
|
(152
|
)
|
(285
|
)
|
(304
|
)
|
||||||||
|
Net cash used in financing activities
|
2,750
|
57
|
2,323
|
(607
|
)
|
|||||||||||
|
Effect of translation adjustments
|
119
|
47
|
(44
|
)
|
21
|
|||||||||||
|
Net increase (decrease) in cash and cash equivalents
|
2,764
|
1,193
|
4,434
|
1,779
|
||||||||||||
|
Cash and cash equivalents at beginning of the period
|
6,406
|
2,214
|
4,735
|
1,628
|
||||||||||||
|
Cash and cash equivalents at period end
|
9,169
|
3,407
|
9,169
|
3,407
|
||||||||||||